| Literature DB >> 28966146 |
Helmut Fuchs1, Juan Antonio Aguilar-Pimentel1, Oana V Amarie2, Lore Becker1, Julia Calzada-Wack1, Yi-Li Cho1, Lillian Garrett2, Sabine M Hölter2, Martin Irmler1, Martin Kistler1, Markus Kraiger1, Philipp Mayer-Kuckuk1, Kristin Moreth1, Birgit Rathkolb3, Jan Rozman4, Patricia da Silva Buttkus1, Irina Treise1, Annemarie Zimprich2, Kristine Gampe1, Christine Hutterer1, Claudia Stöger1, Stefanie Leuchtenberger1, Holger Maier1, Manuel Miller5, Angelika Scheideler5, Moya Wu1, Johannes Beckers6, Raffi Bekeredjian7, Markus Brielmeier5, Dirk H Busch8, Martin Klingenspor9, Thomas Klopstock10, Markus Ollert11, Carsten Schmidt-Weber12, Tobias Stöger13, Eckhard Wolf14, Wolfgang Wurst15, Ali Önder Yildirim13, Andreas Zimmer16, Valérie Gailus-Durner1, Martin Hrabě de Angelis17.
Abstract
Since decades, model organisms have provided an important approach for understanding the mechanistic basis of human diseases. The German Mouse Clinic (GMC) was the first phenotyping facility that established a collaboration-based platform for phenotype characterization of mouse lines. In order to address individual projects by a tailor-made phenotyping strategy, the GMC advanced in developing a series of pipelines with tests for the analysis of specific disease areas. For a general broad analysis, there is a screening pipeline that covers the key parameters for the most relevant disease areas. For hypothesis-driven phenotypic analyses, there are thirteen additional pipelines with focus on neurological and behavioral disorders, metabolic dysfunction, respiratory system malfunctions, immune-system disorders and imaging techniques. In this article, we give an overview of the pipelines and describe the scientific rationale behind the different test combinations.Entities:
Keywords: Gene function analysis; Mouse model; Mouse phenotyping; Phenotyping pipeline
Mesh:
Year: 2017 PMID: 28966146 DOI: 10.1016/j.bbr.2017.09.048
Source DB: PubMed Journal: Behav Brain Res ISSN: 0166-4328 Impact factor: 3.332